Promoted Content Promoted Content

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Hyaluronic Acid,Calcium Hydroxyapatite

            Therapeutic Area: Dermatology Product Name: HArmonyCa

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Innovative Luminera

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Acquisition October 07, 2020

            Details:

            Allergan Aesthetics will acquire Luminera's full dermal filler portfolio and R&D pipeline further enhancing Allergan Aesthetics' leading dermal filler portfolio with its JUVÉDERM® collection of fillers.

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Minocycline Hydrochloride

            Therapeutic Area: Dermatology Product Name: Undisclosed

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Cutia Therapeutics

            Deal Size: $11.0 million Upfront Cash: $10.0 million

            Deal Type: Licensing Agreement April 23, 2020

            Details:

            Cutia will have an exclusive license to obtain regulatory approval and sell AMZEEQ. Foamix is to supply Cutia with the finished licensed products for clinical and commercial use.